TREE NEWS reports: McKesson and private equity firm Clayton Dubilier & Rice are close to a deal to acquire Option Care Health, the largest independent US infusion services provider, at an enterprise value including debt of more than $5 billion. Option Care Health entered advanced talks to sell itself after receiving a joint bid from the two. A deal could be reached as early as Tuesday but is not finalized; CD&R would hold 51% and McKesson 49%, with McKesson holding a right to buy CD&R’s stake in the future.
McKesson, CD&R Near Deal to Acquire Option Care Health
AI take
The structure is the story here: a 51/49 split with a future buyout right effectively hands McKesson a path to full ownership while keeping the asset off its balance sheet for now, a common private-equity construct for consolidating care-delivery assets. It matters because the largest independent US infusion provider would move under a distributor-plus-PE umbrella, further concentrating home and alternate-site care. The open question is whether the deal closes as reported or the talks lapse, and whether that future call right shapes how Option Care is run in the interim.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
5m ago
FTSE China A50 futures rise 0.42% in night session to 13,874
9m ago
Panama Canal to Pilot Long-Term Booking Slots for Panamax Locks
10m ago
Wall Street Banks Lead $60B Chip Financing Deal for Broadcom and Anthropic
10m ago
Houthis Warn Airlines to Halt Flights Through Saudi Airspace
12m ago
US stock index futures close higher; Nasdaq 100 futures up 0.91%
16m ago
Offshore Yuan Closes at 6.7037 per Dollar, Up 21 Pips